Brief: Enorama Pharma Jul-Sept Operating Loss Widens To SEK 3.3 Million
07/11/2018 07:07
Nov 7 (Reuters) - Enorama Pharma AB ERMA.ST :
* JUL-SEPT NET SALES SEK 833,000 VERSUS SEK 0 YEAR AGO
* JUL-SEPT OPERATING LOSS SEK 3.3 MILLION VERSUS LOSS SEK
2.1
MILLION YEAR AGO
Source text for Eikon: ID:nWkrcPmxN
Further company coverage: ERMA.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO